S J Hollenbach Selected Research

BnSO(2)-D-Arg-Gly-Arg-ketothiazole

4/2000

Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S J Hollenbach Research Topics

Disease

1	Anaphylaxis (Anaphylactic Shock) 01/2017
1	Lacerations 01/2017
1	Thrombosis (Thrombus) 04/2000
1	Venous Thrombosis (Deep-Vein Thrombosis) 04/2000
1	Thrombocytopenia (Thrombopenia) 04/2000

Drug/Important Bio-Agent (IBA)

1	Diphenhydramine (Benadryl)FDA LinkGeneric 01/2017
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2017
1	PRT064445IBA 01/2017
1	RivaroxabanIBA 01/2017
1	Factor Xa (Coagulation Factor Xa)IBA 04/2000
1	Enoxaparin (Lovenox)FDA LinkGeneric 04/2000
1	Heparin (Liquaemin)FDA LinkGeneric 04/2000
1	BnSO(2)-D-Arg-Gly-Arg-ketothiazoleIBA 04/2000
1	Hemostatics (Antihemorrhagics)IBA 04/2000
1	phenylalanyl- prolyl- arginine- chloromethyl ketone (PPACK)IBA 04/2000
1	Thrombin FDA Link 04/2000
1	Thromboplastin (Tissue Factor)IBA 04/2000

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2017